Repligen posts 15% revenue growth in Q1 2026, raises full-year EPS guidance to $1.97-$2.05

Repligen reported a strong Q1 2026 with $194 million revenue, up 15% year-over-year, driven by 11% organic growth. GAAP EPS rose 50% to $0.15, while adjusted EPS increased 23% to $0.48. The company reaffirmed its full-year organic revenue growth guidance of 9%-13% and raised its adjusted EPS forecast to $1.97-$2.05, reflecting confidence in continued profitable growth. Strategic moves include a new partnership in China, divestiture of a non-core business, and launching a Transformation Office to enhance margins and operational efficiency.